142 related articles for article (PubMed ID: 14767998)
1. Bile acids enhance the activity of the insulin receptor and glycogen synthase in primary rodent hepatocytes.
Han SI; Studer E; Gupta S; Fang Y; Qiao L; Li W; Grant S; Hylemon PB; Dent P
Hepatology; 2004 Feb; 39(2):456-63. PubMed ID: 14767998
[TBL] [Abstract][Full Text] [Related]
2. Bile acids induce mitochondrial ROS, which promote activation of receptor tyrosine kinases and signaling pathways in rat hepatocytes.
Fang Y; Han SI; Mitchell C; Gupta S; Studer E; Grant S; Hylemon PB; Dent P
Hepatology; 2004 Oct; 40(4):961-71. PubMed ID: 15382121
[TBL] [Abstract][Full Text] [Related]
3. Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin-sensitive mechanism in murine and human hepatocytes.
Dent P; Fang Y; Gupta S; Studer E; Mitchell C; Spiegel S; Hylemon PB
Hepatology; 2005 Dec; 42(6):1291-9. PubMed ID: 16317705
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of insulin/IGF-1 receptor signaling enhances bile acid toxicity in primary hepatocytes.
Dent P; Han SI; Mitchell C; Studer E; Yacoub A; Grandis J; Grant S; Krystal GW; Hylemon PB
Biochem Pharmacol; 2005 Nov; 70(11):1685-96. PubMed ID: 16207485
[TBL] [Abstract][Full Text] [Related]
5. Conjugated bile acids regulate hepatocyte glycogen synthase activity in vitro and in vivo via Galphai signaling.
Fang Y; Studer E; Mitchell C; Grant S; Pandak WM; Hylemon PB; Dent P
Mol Pharmacol; 2007 Apr; 71(4):1122-8. PubMed ID: 17200418
[TBL] [Abstract][Full Text] [Related]
6. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
7. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
Dokken BB; Sloniger JA; Henriksen EJ
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
[TBL] [Abstract][Full Text] [Related]
8. Specific inhibition by hGRB10zeta of insulin-induced glycogen synthase activation: evidence for a novel signaling pathway.
Mounier C; Lavoie L; Dumas V; Mohammad-Ali K; Wu J; Nantel A; Bergeron JJ; Thomas DY; Posner BI
Mol Cell Endocrinol; 2001 Feb; 173(1-2):15-27. PubMed ID: 11223174
[TBL] [Abstract][Full Text] [Related]
9. Alterations of nPKC distribution, but normal Akt/PKB activation in denervated rat soleus muscle.
Lin Y; Brady MJ; Wolanske K; Holbert R; Ruderman NB; Yaney GC
Am J Physiol Endocrinol Metab; 2002 Aug; 283(2):E318-25. PubMed ID: 12110537
[TBL] [Abstract][Full Text] [Related]
10. Differential signaling of insulin and IGF-1 receptors to glycogen synthesis in murine hepatocytes.
Park BC; Kido Y; Accili D
Biochemistry; 1999 Jun; 38(23):7517-23. PubMed ID: 10360949
[TBL] [Abstract][Full Text] [Related]
11. Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampal neurons.
Matsuzaki H; Tamatani M; Mitsuda N; Namikawa K; Kiyama H; Miyake S; Tohyama M
J Neurochem; 1999 Nov; 73(5):2037-46. PubMed ID: 10537063
[TBL] [Abstract][Full Text] [Related]
12. Cyclin kinase inhibitor p21 potentiates bile acid-induced apoptosis in hepatocytes that is dependent on p53.
Qiao L; McKinstry R; Gupta S; Gilfor D; Windle JJ; Hylemon PB; Grant S; Fisher PB; Dent P
Hepatology; 2002 Jul; 36(1):39-48. PubMed ID: 12085347
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis for the insulinomimetic effects of C-peptide.
Grunberger G; Qiang X; Li Z; Mathews ST; Sbrissa D; Shisheva A; Sima AA
Diabetologia; 2001 Oct; 44(10):1247-57. PubMed ID: 11692173
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase Cδ but not PKCα is involved in insulin-induced glucose metabolism in hepatocytes.
Brutman-Barazani T; Horovitz-Fried M; Aga-Mizrachi S; Brand C; Brodie C; Rosa J; Sampson SR
J Cell Biochem; 2012 Jun; 113(6):2064-76. PubMed ID: 22271577
[TBL] [Abstract][Full Text] [Related]
15. Sustained Akt/PKB activation and transient attenuation of c-jun N-terminal kinase in the inhibition of apoptosis by IGF-1 in vascular smooth muscle cells.
Allen RT; Krueger KD; Dhume A; Agrawal DK
Apoptosis; 2005 May; 10(3):525-35. PubMed ID: 15909115
[TBL] [Abstract][Full Text] [Related]
16. Insulin, insulin-like growth factor-I, and platelet-derived growth factor activate extracellular signal-regulated kinase by distinct pathways in muscle cells.
Tsakiridis T; Tsiani E; Lekas P; Bergman A; Cherepanov V; Whiteside C; Downey GP
Biochem Biophys Res Commun; 2001 Oct; 288(1):205-11. PubMed ID: 11594774
[TBL] [Abstract][Full Text] [Related]
17. A role for Akt in epidermal growth factor-stimulated cell cycle progression in cultured hepatocytes: generation of a hyperproliferative window after adenoviral expression of constitutively active Akt.
Luo Y; Dixon CJ; Hall JF; White PJ; Boarder MR
J Pharmacol Exp Ther; 2007 Jun; 321(3):884-91. PubMed ID: 17371807
[TBL] [Abstract][Full Text] [Related]
18. Activation of the Raf-1/MEK/ERK cascade by bile acids occurs via the epidermal growth factor receptor in primary rat hepatocytes.
Rao YP; Studer EJ; Stravitz RT; Gupta S; Qiao L; Dent P; Hylemon PB
Hepatology; 2002 Feb; 35(2):307-14. PubMed ID: 11826403
[TBL] [Abstract][Full Text] [Related]
19. L-leucine availability regulates phosphatidylinositol 3-kinase, p70 S6 kinase and glycogen synthase kinase-3 activity in L6 muscle cells: evidence for the involvement of the mammalian target of rapamycin (mTOR) pathway in the L-leucine-induced up-regulation of system A amino acid transport.
Peyrollier K; Hajduch E; Blair AS; Hyde R; Hundal HS
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):361-8. PubMed ID: 10947949
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathway.
del Rincón SV; Rousseau C; Samanta R; Miller WH
Oncogene; 2003 May; 22(22):3353-60. PubMed ID: 12776186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
